Reselute develops solutions for the treatment of orthopaedic implant related infections.
Reselute has raised $75K in total funding. The most recent round was Grant. The last funding was announced in September 2026.
Reselute's investors include National Science Foundation, North Carolina Department of Commerce, One North Carolina Small Business Program.
Reselute is headquartered in Durham, United States.
Reselute develops solutions for the treatment of orthopaedic implant related infections.
Reselute is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Reselute — Funding & Investors." VCBacked, September 3, 2026, https://www.vcbacked.co/company/reselute. Accessed November 13, 2026.
VCBacked. (2026). Reselute — Funding & Investors. Retrieved November 13, 2026, from https://www.vcbacked.co/company/reselute
{{cite web |title=Reselute — Funding & Investors |url=https://www.vcbacked.co/company/reselute |website=VCBacked |access-date=November 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at Reselute? Request a listing update